CIMBAN Trademark

Trademark Overview


On Monday, May 20, 2024, a trademark application was filed for CIMBAN with the United States Patent and Trademark Office. The USPTO has given the CIMBAN trademark a serial number of 98558902. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 8, 2025. This trademark is owned by Camena Bioscience Limited. The CIMBAN trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Chemicals for use in the biochemical and chemical industry; Chemical substances for use in the production of drugs, pharmaceuticals and antibodies; Active chemical ingredients for use in the production of drugs, pharmaceuticals and antibodies; DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for scientific and research use; Nucleic acids comprising synthetic nucleotides for scientific and research use; Synthetic DNA nucleotides, synthetic RNA nucleotides, synthetic genes being biotechnologically formed genes, synthetic oligonucleotides and synthetic proteins for laboratory, scientific and industrial use; Chemical preparations, namely, synthetic enzymes, gene editing enzymes, DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for laboratory, scientific and industrial purposes; Synthetic DNA and RNA nucleotides for scientific and medical research; synthetic DNA ...

Consultancy in relation to biochemistry and biotechnology; Research and development in the field of biotechnology and synthetic biology; Biological analysis; Biotechnological research relating to enzymatic synthesis; Provision of gene synthesis solutions, namely, creating and modifying genetic sequences for scientific purposes; Development and test of enzyme production methods; Evaluations, estimates, research and preparing related reports and technical documentation of genetic materials all in the field of enzymatic production; Scientific and technological services in the field of biotechnology consisting of the development of innovative processes to produce synthetic genes; Genetic engineering, namely, production of nucleic acid sequences; Research and development services relating to the creation of synthetic nucleic acid sequences; Genetic engineering services being the design, development, and testing of synthetic gene sequences; Design, development, rental and leasing of test and...
cimban

General Information


Serial Number98558902
Word MarkCIMBAN
Filing DateMonday, May 20, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2025

Trademark Statements


Goods and ServicesChemicals for use in the biochemical and chemical industry; Chemical substances for use in the production of drugs, pharmaceuticals and antibodies; Active chemical ingredients for use in the production of drugs, pharmaceuticals and antibodies; DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for scientific and research use; Nucleic acids comprising synthetic nucleotides for scientific and research use; Synthetic DNA nucleotides, synthetic RNA nucleotides, synthetic genes being biotechnologically formed genes, synthetic oligonucleotides and synthetic proteins for laboratory, scientific and industrial use; Chemical preparations, namely, synthetic enzymes, gene editing enzymes, DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for laboratory, scientific and industrial purposes; Synthetic DNA and RNA nucleotides for scientific and medical research; synthetic DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for use in medical biologics and therapeutics; Molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, XNA, oligonucleotides, genes and proteins.
Goods and ServicesConsultancy in relation to biochemistry and biotechnology; Research and development in the field of biotechnology and synthetic biology; Biological analysis; Biotechnological research relating to enzymatic synthesis; Provision of gene synthesis solutions, namely, creating and modifying genetic sequences for scientific purposes; Development and test of enzyme production methods; Evaluations, estimates, research and preparing related reports and technical documentation of genetic materials all in the field of enzymatic production; Scientific and technological services in the field of biotechnology consisting of the development of innovative processes to produce synthetic genes; Genetic engineering, namely, production of nucleic acid sequences; Research and development services relating to the creation of synthetic nucleic acid sequences; Genetic engineering services being the design, development, and testing of synthetic gene sequences; Design, development, rental and leasing of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids and genetic materials; Genetic engineering services, namely, manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; Genetic engineering and scientific laboratory services being the design, development and testing of synthetic gene sequences in complex gene production; Research and development services in the field of nucleic acid synthesis technology; Technical consulting in the field of biotechnology; Genetic engineering, namely, production of complex gene sequences; Consultancy, advisory and information services related to the aforementioned services; Software-as-a-Service (SaaS) services featuring software with a bioinformatics algorithm for use in designing gene assembly paths; Platform-as-a Service (PaaS) services featuring software platforms with a bioinformatics algorithm for use in designing gene assembly paths.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, May 20, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 20, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCamena Bioscience Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSAFFRON WALDEN, Essex CB101XL
GB

Party NameCamena Bioscience Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSAFFRON WALDEN, Essex CB101XL
GB

Trademark Events


Event DateEvent Description
Monday, May 20, 2024NEW APPLICATION ENTERED
Friday, November 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 18, 2024NON-FINAL ACTION E-MAILED
Wednesday, December 4, 2024ASSIGNED TO EXAMINER
Wednesday, December 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 18, 2024NON-FINAL ACTION WRITTEN
Thursday, March 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 2, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 8, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 8, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED